Cancer of Kidney
14
2
3
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
14.3%
2 terminated out of 14 trials
71.4%
-15.1% vs benchmark
0%
0 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Tempus Priority Study: A Pan-tumor Observational Study
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
Low-moderate Intensity Pedaling During Immunotherapy Administration
Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Microwave Coagulation in Partial Nephrectomy Protocol